WHO informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines, Geneva, Switzerland, 7-8 April 2005

Biologicals

Volumn 35, Issue 1, 2007, Pages 63-71

  Shin, Jinho ^a   Wood, David ^a   Robertson, James ^b   Minor, Philip ^b   Peden, Keith ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; VIRUS VACCINE;

CONFERENCE PAPER; CONSULTATION; DNA MICROARRAY; DNA SEQUENCE; DOT HYBRIDIZATION; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; SWITZERLAND; VACCINATION; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

BCG VACCINE; HUMANS; MOLECULAR PROBE TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLIOVIRUS VACCINES; QUALITY CONTROL; SAFETY; SWITZERLAND; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 33847127016     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2005.12.005     Document Type: Conference Paper

References (2)

1. Acceptability of cell substrates for production of biologicals. Report of a WHO study group (1987), World Health Organization, Geneva [WHO technical report series no. 747]
2. Requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirement for biological substance no. 50). WHO expert committee on biological standardization (1998), World Health Organization, Geneva Annex 1 [WHO technical report series no. 878]